Hemorrhage Risk Prescribed Arixtra

CompletedOBSERVATIONAL

Enrollment

13,442

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Thrombosis, Venous

Interventions

DRUG

Fondaparinux sodium

Fondaparinux sodium for thromboprophylaxis (ATC: B01AX05)

DRUG

Low molecular weight heparin (LMWH)

LMWH including: dalteparin, nadroparin, enoxaparin or tinzaparin (ATC:B01AB (excluding B01AB01))